0002132799-26-000001.txt : 20260508 0002132799-26-000001.hdr.sgml : 20260508 20260507212721 ACCESSION NUMBER: 0002132799-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260508 DATE AS OF CHANGE: 20260507 EFFECTIVENESS DATE: 20260508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Illexcor Therapeutics, Inc. CENTRAL INDEX KEY: 0002132799 ORGANIZATION NAME: EIN: 832366115 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-583301 FILM NUMBER: 26955772 BUSINESS ADDRESS: STREET 1: 800 E. LEIGH STREET, SUITE 19 CITY: RICHMOND STATE: VA ZIP: 23219 BUSINESS PHONE: (650) 935 5772 MAIL ADDRESS: STREET 1: 800 E. LEIGH STREET, SUITE 19 CITY: RICHMOND STATE: VA ZIP: 23219 D 1 primary_doc.xml X0708 D LIVE 0002132799 Illexcor Therapeutics, Inc. 11924 Evening Loop HENRICO VA VIRGINIA 23233 (650) 935 5772 DELAWARE Illexcor Therapeutics LLC None Corporation true 2026 Andrew N Fleischman 1100 Ludlow St. Apt 1712 Philadelphia PA PENNSYLVANIA 19107 Executive Officer Director Timothy E Ladin 185 Spruce Lane Dorset VT VERMONT 05251 Executive Officer Giovanni Mariggi 10 Cours de Rive Geneva V8 SWITZERLAND 1204 Director Maneka Mirchandaney 660 Fifth Avenue New York NY NEW YORK 10103 Director Ted Love 19870 7th Street East Sonoma CA CALIFORNIA 95476 Director Biotechnology $1,000,001 - $5,000,000 06b false 2026-04-15 true true false 1000000 69000000 13000000 56000000 Total amount remaining to be sold is subject to milestones in agreement. false 6 0 0 800000 true false Illexcor Therapeutics, Inc. Timothy E Ladin Timothy E Ladin Chief Legal Officer 2026-05-07